Navigation Links
Gordon, Familant Join Baker Botts as Part of Expanded Life Sciences IP Initiative

Partners' Careers Focus on Biotech, Pharmaceutical Patents

NEW YORK, Jan. 12 /PRNewswire/ -- Jennifer Gordon and Scott Familant, who have extensive experience in complex patent matters in the life sciences, joined Baker Botts L.L.P. January 5, 2009, as partners in the Intellectual Property Department. Gordon will head up the IP Department's Life Sciences section. Both lawyers will be based in the firm's New York City office.



Throughout their careers, Gordon and Familant have procured, litigated and provided counsel on patents involving virtually all aspects of biotechnology, most notably litigating foundational patents in the areas of nucleic acid amplification and recombinant antibody production. Their pharmaceutical patent experience encompasses a broad spectrum, from the earliest therapeutic proteins and monoclonal antibodies to recent blockbuster drugs for lowering cholesterol and treating type II diabetes.

"Jennifer and Scott joining Baker Botts at this time demonstrates our commitment to recruiting highly-skilled individuals with extensive experience in areas where our clients are increasingly looking to us for counsel," said Baker Botts Managing Partner Walt Smith. "With a focus on life science matters, the addition of Jennifer and Scott to our talented team of IP lawyers increases our depth of knowledge and legal expertise in the intellectual property arena."

Commenting on the move to Baker Botts, Gordon said: "Baker Botts' strategic focus on the life sciences and its exceptional full service intellectual property practice were very attractive to Scott and me. We look forward to working with a deep and talented bench of IP practitioners, and I, personally, am pleased to take on the leadership of the firm's expanding life sciences IP practice."

Prior to joining Baker Botts, Gordon and Familant were partners at Sidley Austin L.L.P. They both have advanced scientific and technical training. Gordon has a PhD in Biochemical Engineering from M.I.T. She received her J.D., cum laude, in 1985 from Fordham University School of Law. Familant earned a bachelor's degree in Chemistry from Cornell University. He received his J.D. from The George Washington University in 1990. Both Gordon and Familant are frequent lecturers on intellectual property topics and have authored articles on a range of patent issues that impact life sciences patents.

Baker Botts has one of the nation's largest IP teams with more than 140 intellectual property lawyers working in six U.S. offices and its London office. Most of the firm's IP lawyers hold science and engineering degrees and are members of the patent bar. More information about the Intellectual Property Department at Baker Botts is available here.

Additional background on Jennifer Gordon is available here.

Additional background on Scott Familant is available here.

About Baker Botts L.L.P.

Baker Botts L.L.P., dating from 1840, is a leading international law firm with offices in Austin, Beijing, Dallas, Dubai, Hong Kong, Houston, London, Moscow, New York, Palo Alto (California), Riyadh and Washington. With approximately 820 lawyers, Baker Botts provides a full range of legal services to international, national and regional clients. For more information, please visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.


Available Topic Expert(s): For information on the listed expert(s), click appropriate link.


SOURCE Baker Botts L.L.P.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
2. Isabellas Healthy Bakery Unveils Activate - A New Probiotic Muffin Fortified with GanedenBC30 Probiotic
3. VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
4. Align Technology Receives Expanded Regulatory Approval in Japan
5. Biotech Endorsement Insurance Discount Expanded to Nebraska, Kansas Growers Planting Corn with HERCULEX XTRA Traits
6. Backe Digital-Brand-Marketing Blends Traditional Advertising with Expanded Digital Services
7. ACIST Medical Systems Announces the Opening of Its New Expanded Corporate Headquarters in Eden Prairie, MN
8. Codexis, Arch Announce Expanded Collaboration
9. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
10. Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test
11. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
Post Your Comments:
(Date:11/25/2015)... -- 2 nouvelles études permettent d , ... entre les souches bactériennes retrouvées dans la plaque ... . Ces recherches  ouvrent une nouvelle voie ... efficace de l,un des problèmes de santé les ...    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... LOS ANGELES and HOLLISTON, Mass. ... Regenerative Technology, Inc. (Nasdaq: HART ), a biotechnology ... announced that CEO Jim McGorry will present ... Tuesday, December 1, 2015 at 2:30 p.m. PT. The ... (link below) for 30 days. Management will also be ...
(Date:11/25/2015)... 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; ... and prospects remain fundamentally strong and highlights the ... recently received DSMB recommendation to continue the ZoptEC ... of the final interim efficacy and safety data ... in men with heavily pretreated castration- and Taxane-resistant ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):